Gene · 10643
Papers3,038
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,038
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| Identification of a three-gene prognostic signature for radioresistant esophageal squamous cell carcinoma. | World J Clin Oncol | 2023 | 36699628 | PubTator, text mining | PubMed |
| Characterization of circSCL38A1 as a novel oncogene in bladder cancer via targeting ILF3/TGF-β2 signaling axis. | Cell Death Dis | 2023 | 36697384 | PubTator, text mining | PubMed |
| Corrigendum to "Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation" [EBioMedicine 41 (2019) 357-369]. | EBioMedicine | 2023 | 36696815 | PubTator, text mining | PubMed |
Insulin-like growth factor-2 mRNA-binding protein 3 promotes cell migration, invasion, and epithelial-mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E-box-binding homeobox 1 mRNA. | Mol Carcinog | 2023 | 36688673 | PubTator, text mining | PubMed |
| Severe Burn Injury Significantly Alters the Gene Expression and m6A Methylation Tagging of mRNAs and lncRNAs in Human Skin. | J Pers Med | 2023 | 36675811 | PubTator, text mining | PubMed |
| Interacting Networks of the Hypothalamic-Pituitary-Ovarian Axis Regulate Layer Hens Performance. | Genes (Basel) | 2023 | 36672882 | PubTator, text mining | PubMed |
| Silencing of circCRIM1 Drives IGF2BP1-Mediated NSCLC Immune Evasion. | Cells | 2023 | 36672208 | PubTator, text mining | PubMed |
| Ascorbic acid protects retinal pigment epithelial cells from high glucose by inhibiting the NF-κB signal pathway through MALAT1/IGF2BP3 axis. | Diabet Med | 2023 | 36661363 | PubTator, text mining | PubMed |
| Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis. | J Cancer Res Clin Oncol | 2023 | 36656379 | PubTator, text mining | PubMed |
| The Prognostic Value of a lncRNA Risk Model Consists of 9 m6A Regulator-Related lncRNAs in Hepatocellular Carcinoma (HCC). | Evol Bioinform Online | 2023 | 36655172 | PubTator, text mining | PubMed |
| The function and clinical implication of YTHDF1 in the human system development and cancer. | Biomark Res | 2023 | 36650570 | PubTator, text mining | PubMed |
| STRIP2 motivates non-small cell lung cancer progression by modulating the TMBIM6 stability through IGF2BP3 dependent. | J Exp Clin Cancer Res | 2023 | 36639675 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia. | Mol Cell | 2023 | 36634675 | PubTator, text mining | PubMed |
| Proteomic screening identifies RPLp2 as a specific regulator for the translation of coronavirus. | Int J Biol Macromol | 2023 | 36632964 | PubTator, text mining | PubMed |
| Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner. | Int J Biol Sci | 2023 | 36632454 | PubTator, text mining | PubMed |
| Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m6A modification. | Theranostics | 2023 | 36632223 | PubTator, text mining | PubMed |
| Proteomics-based determination of double-stranded RNA interactome reveals known and new factors involved in Sindbis virus infection. | RNA | 2023 | 36617674 | PubTator, text mining | PubMed |
| Glucose dissociates DDX21 dimers to regulate mRNA splicing and tissue differentiation. | Cell | 2023 | 36608661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10643/papers?page=43